The Role of Allogeneic Transplantation in Chronic Myeloid Leukemia in 2023: A Case-Based Concise Review

Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of chronic myeloid leukemia (CML), granting patients a life expectancy close to that of the normal population and, in a subset of patients, the possibility to discontinue therapy. Nonetheless, for a not negligible minority of patien...

Description complète

Détails bibliographiques

Auteurs principaux:	Mario Tiribelli, Giuseppe Petruzzellis, Giulia Battaglia, Martina Pucillo, Marta Lisa Battista, Michela Cerno, Antonella Geromin, Gabriele Facchin, Umberto Pizzano, Daniela Damiani, Renato Fanin, Francesca Patriarca
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2023-08-01
Collection:	Hemato
Sujets:	chronic myeloid leukemia allogeneic stem cell transplantation TKIs GVHD
Accès en ligne:	https://www.mdpi.com/2673-6357/4/3/20
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!